Jagoda EM - Search Results

1

In vivo muscarinic binding selectivity of (R,S)- and (R,R)-[18F]-fluoromethyl QNB.

Kiesewetter DO, Carson RE, Jagoda EM, Endres CJ, Der MG, Herscovitch P, Eckelman WC. Kiesewetter DO, et al. Among authors: jagoda em. Bioorg Med Chem. 1997 Aug;5(8):1555-67. doi: 10.1016/s0968-0896(97)00100-4. Bioorg Med Chem. 1997. PMID: 9313861

2

Synthesis and in vivo biodistribution of F-18 labeled 3-cis-, 3-trans-, 4-cis-, and 4-trans-fluorocyclohexane derivatives of WAY 100635.

Lang L, Jagoda E, Ma Y, Sassaman MB, Eckelman WC. Lang L, et al. Bioorg Med Chem. 2006 Jun 1;14(11):3737-48. doi: 10.1016/j.bmc.2006.01.064. Epub 2006 Feb 20. Bioorg Med Chem. 2006. PMID: 16488611

3

Muscarinic cholinergic receptor measurements with [18F]FP-TZTP: control and competition studies.

Carson RE, Kiesewetter DO, Jagoda E, Der MG, Herscovitch P, Eckelman WC. Carson RE, et al. J Cereb Blood Flow Metab. 1998 Oct;18(10):1130-42. doi: 10.1097/00004647-199810000-00010. J Cereb Blood Flow Metab. 1998. PMID: 9778190

4

Development of fluorine-18-labeled 5-HT1A antagonists.

Lang L, Jagoda E, Schmall B, Vuong BK, Adams HR, Nelson DL, Carson RE, Eckelman WC. Lang L, et al. J Med Chem. 1999 May 6;42(9):1576-86. doi: 10.1021/jm980456f. J Med Chem. 1999. PMID: 10229627

5

In vivo muscarinic binding of 3-(alkylthio)-3-thiadiazolyl tetrahydropyridines.

Kiesewetter DO, Carson RE, Jagoda EM, Herscovitch P, Eckelman WC. Kiesewetter DO, et al. Among authors: jagoda em. Synapse. 1999 Jan;31(1):29-40. doi: 10.1002/(SICI)1098-2396(199901)31:1<29::AID-SYN5>3.0.CO;2-9. Synapse. 1999. PMID: 10025681

6

Using single photon emission tomography (SPECT) and positron emission tomography (PET) to trace the distribution of muscarinic acetylcholine receptor (MACHR) binding radioligands.

Kiesewetter DO, Carson RE, Jagoda EM, Herscovitch P, Eckelman WC. Kiesewetter DO, et al. Among authors: jagoda em. Life Sci. 1999;64(6-7):511-8. doi: 10.1016/s0024-3205(98)00595-5. Life Sci. 1999. PMID: 10069517 Review.

7

Regional brain uptake of the muscarinic ligand, [18F]FP-TZTP, is greatly decreased in M2 receptor knockout mice but not in M1, M3 and M4 receptor knockout mice.

Jagoda EM, Kiesewetter DO, Shimoji K, Ravasi L, Yamada M, Gomeza J, Wess J, Eckelman WC. Jagoda EM, et al. Neuropharmacology. 2003 Apr;44(5):653-61. doi: 10.1016/s0028-3908(03)00050-9. Neuropharmacology. 2003. PMID: 12668051

8

Inhibition of [18F]FP-TZTP binding by loading doses of muscarinic agonists P-TZTP or FP-TZTP in vivo is not due to agonist-induced reduction in cerebral blood flow.

Shimoji K, Esaki T, Itoh Y, Ravasi L, Cook M, Jehle J, Jagoda EM, Kiesewetter DO, Schmidt K, Sokoloff L, Eckelman WC. Shimoji K, et al. Among authors: jagoda em. Synapse. 2003 Nov;50(2):151-63. doi: 10.1002/syn.10257. Synapse. 2003. PMID: 12923818

9

Identification of metabolites of fluorine-18-labeled M2 muscarinic receptor agonist, 3-(3-[(3-fluoropropyl)thio]-1,2,5-thiadiazol-4-yl)-1,2,5,6-tetrahydro-1-methylpyridine, produced by human and rat hepatocytes.

Ma Y, Kiesewetter DO, Jagoda EM, Huang BX, Eckelman WC. Ma Y, et al. Among authors: jagoda em. J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Jan 25;766(2):319-29. doi: 10.1016/s0378-4347(01)00517-5. J Chromatogr B Analyt Technol Biomed Life Sci. 2002. PMID: 11824820

10

Fluoro-, bromo-, and iodopaclitaxel derivatives: synthesis and biological evaluation.

Kiesewetter DO, Jagoda EM, Kao CH, Ma Y, Ravasi L, Shimoji K, Szajek LP, Eckelman WC. Kiesewetter DO, et al. Among authors: jagoda em. Nucl Med Biol. 2003 Jan;30(1):11-24. doi: 10.1016/s0969-8051(02)00351-7. Nucl Med Biol. 2003. PMID: 12493538

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

92 results

Search Page